Strategy Driven

JANUARY 5, 2020

The investment market dealing with precious metals has barely made the cut in terms of popularity among people, and it’s not something many people tap into, if they do hear about it, it’s mostly for either gold, silver or palladium. One such example is that of a large Swiss-based pharmaceutical company that invested around $11.3

Price 66

Price Short-term Long-term Globalization 66

HR Digest

NOVEMBER 10, 2021

Ramcess Jean-Loiuis, Pfizer’s Chief Diversity, Equity & Inclusion (DEI) Officer, is not short on ambition. Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. These groups provide a forum from which all colleagues can benefit. colleagues.

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

Harvard Business Review

MAY 7, 2015

Here’s a conundrum: On the one hand, there’s a consensus among thoughtful business leaders that too many companies are sacrificing long-term growth on the altar of smooth, reliable short-term earnings. HBR: What got you interested in what impact short-term earnings management has on long-term performance?

Short-term 8

Short-term Henderson Long-term Metrics 8

Strategy Driven

JULY 13, 2011

While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Examines ways to maintain and grow value through mergers, acquisitions, and portfolio management.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Coaching Tip

MARCH 15, 2011

In a capitalist democracy, government should not be involved with what we in the private sector do, which is managing time to manage money. Al Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop. So sue me” was the response.

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity. ” .”

Diversity 94

Diversity Innovation Biotechnology Short-term 94

Harvard Business Review

MAY 31, 2018

A 2014 global survey of more than 600 C-suite executives and directors, conducted by the non-profit Focusing Capital for the Long Term (FCLT), reported that two-thirds of those surveyed said pressure for short-term results had increased over the previous five years. And short-term thinking since that survey has not abated.

CEO 8

CEO Short-term Long-term McKinsey 8

Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. They overcame short-term thinking. A majority of public companies pledge allegiance to short-term profit over long-term vision. But it does happen.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". Some large investors already have a long-term view. CEOs can seek to attract long-term investors in several ways: 1. Take consumer goods giant Unilever.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

JULY 8, 2016

Xiaomi’s phones are not technologically disruptive in hardware terms, but they are revolutionary in customer experience terms; customers come to expect and appreciate their weekly OS updates. We spoke with several Chinese entrepreneurs in Kunshan last month — young and old, working in both the private sector and the public.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. from that of a fully integrated pharmaceutical company into a company that retained key technical expertise (e.g., Accordingly, I transformed the business model ?

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

SEPTEMBER 21, 2018

Boards’ abilities to foster innovation clearly fall short when compared with their other activities. Still, it’s telling that board members rate their boards better on risk management than on innovation. We also found that a focus on innovation tends to go hand in hand with longer-term time horizons.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

DECEMBER 14, 2017

This tends to focus doctors, nurses, and other health professionals on the value of what they do — finding the most cost-effective approach to managing their patients’ problems. The involved companies will face short-term pressure to prove the profitability of the new arrangements.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

DECEMBER 16, 2014

The term “czar,” used widely by the press and even some in government, was unfortunate; it couldn’t be more opposed to Obama’s concept of improved collaboration. Top-down management simply will not get the innovation part of the job done. This process is deliberately fluid, adjusting as the situation changes.

Management 9

Management Health Care NGO Crisis Management 9

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Christensen has even re-entered the fold clarifying what he means when he uses the term. Is 23andMe potentially disruptive to pharmaceutical companies? Professor Clayton M.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

SEPTEMBER 26, 2011

The stock market is short-term-oriented. Stock-based incentive compensation aligns the self-interest of management with shareholders, and a performance-based pay system increases employee motivation. In my experience, these beliefs have led managers and boards to take actions that have had unintended, destructive consequences.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

SEPTEMBER 13, 2011

But only athletic events produce clear winners and losers in the short-term — and most organizations are not actively engaged in those. Rather, we need to better understand how these numbers were achieved and what they are actually saying about a company's long-term health.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

OCTOBER 28, 2011

The story is a familiar one: A company's quarterly earnings fall significantly short of the investment community's expectations, and the CEO announces a restructuring, including a cut in R&D, to lower costs, regardless of the negative impact on the firm's long-term prospects. Not necessarily. Not necessarily.

CEO 10

CEO Short-term Long-term Restructuring 10

Harvard Business Review

SEPTEMBER 14, 2017

A less aggressive mix (say 75:25) is typical in industries such as pharmaceuticals that want salespeople to focus on customer education, and for technical sales jobs that have a large problem-solving component. a high second number) motivates salespeople to drive short-term results.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

MAY 24, 2012

Every large financial services company has instituted risk management, but that hasn't prevented risky behavior in the form of office politics and personality conflict — as the JP Morgan trading debacle has demonstrated. Risk management isn't exclusive to banking. Risk management isn't exclusive to banking.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

JANUARY 10, 2014

I see a rise in business combinations of all kinds — not just M&A, but also partnerships, alliances, joint ventures, and consortia that stop short of being full mergers. But it will be important for managers to know when to use each of these types of deals. And therein lay serious challenges for managers.

Restructuring 8

Restructuring Trends Long-term Short-term 8

Harvard Business Review

JUNE 29, 2015

At the same time, there are certain ways LBOs can actually make it easier for firms to invest in the long term. Because of their relationships with banks, PE funds can get financing much cheaper than target companies could under their current management. LBOs can help firms that are financially constrained invest in innovation.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. When he started at his company, it was young, relatively small, and doing cutting-edge research. Why did they try to make Paul's company just like their own?

COO 11

COO Short-term Pharmaceuticals Innovation 11

Harvard Business Review

APRIL 16, 2012

Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g., high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. Facilitate Investments. Arguments Against Strategic Cash.

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

FEBRUARY 26, 2013

For sales managers, this is not an easy question to answer. One pharmaceutical company's overly-cautious sales force expansion strategy resulted in too little support for a new product launch and cost the company 17% of profits over three years. As a result, they sacrifice long-term profitability.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

AUGUST 14, 2018

The term “digital firms” refers to those companies that from their inception have focused on digital services enabled by the internet and related technologies, including mobile. poor management of relations with Chinese regulators and the government. failure to manage relations effectively with local business partners.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Another problem we’ve seen is that some providers, seeking to fit in to a payment cycle, focus on short-term results, losing sight of the end goals. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. However, equally rare is tapping into the minds of a group of imaginative, open-minded employees and managers to scope out potential strategic opportunities. paul Garbett for HBR.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

MARCH 14, 2017

Year-on-year price increases for existing therapies have allowed the industry to maintain profitability, but those short-term fixes have come at a heavy cost: decreased public satisfaction with the industry and increased political scrutiny. Roivant’s first response was to address misaligned incentives.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

OCTOBER 22, 2013

She kicked off her October management team meeting, which I was attending, by reading the following passage from my book: The dangers of taking too much risk are very clear. I felt that Walter had just given the management team a well-deserved kick in the pants—and they summarily dismissed it without letting it sink in.

COO 8

COO Short-term CFO Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2013

With scarcely any help from management, knowledge workers can increase their productivity by 20%. Yet here is the challenge you face as a senior executive: You cannot manage your knowledge workers in the traditional and intrusive way you might have done with manual workers.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

FEBRUARY 11, 2016

McKesson, the US-based pharmaceutical and health-care giant, benefits from external expertise as a strategic extension of its resources in areas such as business strategy and logistics support. ” Most managers would never dream of treating externals like internals. One of the main problems is decision making. Adapted from.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

JUNE 20, 2017

Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication. Leaders should not be too quick or simplistic in their translation of social movement dynamics into change management plans. Creating a sense of urgency is helpful, but can be short-lived.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

APRIL 24, 2017

Because the long-term horizon and trade-offs required to develop scalable responses to pandemic threats are exactly the type of problem too big to be solved by any one sector. and the global community can manage them. In short, we must adopt a global “invest now or pay later” economic philosophy. Private sector.

Project 9

Project Disaggregation Globalization Comparison 9

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8